Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells

International Journal of Oncology

Volumn 8, Issue 4, 1996, Pages 815-820

  Joshi, Shantaram S ^a   Wu, Ai G ^a   Verbik, David J ^a   Algarra, S M ^a,b   Bishop, Michael R ^b   Pirruccello, Samuel J ^b   Iversen, Patrick L ^b   Jackson Jr , John D ^b   Kessinger, M Anne ^b   Sharp, J Graham ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antisense oligonucleotides; Apoptosis; Burkitt lymphoma; c myb; Raji cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C MYB; PRIORITY JOURNAL;

EID: 0029872891     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.4.815     Document Type: Article

References (18)

1. Nieborowska SM, Nakashima M, Ratjczak M, Steplewski Z, Calabretta B and Skorski T: Oncogene-targeted antisense oligonucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment? Folia Histochem Cytobiol 32: 35-40, 1994.
2. Citro G, Szczylik C, Ginobbi P, Zubi G and Calabretta B: Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligonucleotides into HL-60 cells. Br J Cancer 69: 463-467, 1994.
3. Gewirtz AM: Therapeutic applications of antisense DNA in the treatment of human leukemia. Ann NY Acad Sci 11: 178-187, 1993.
4. Cuddihy AE, Brents LA, Aziz N, Benders TP and Kuehl WM: Only DNA binding and transactivation domains of c-myb are required to block terminal differentiation of murine erythroleukemia cells. Mol Cell Biol 13: 3505-3513, 1993.
5. Citro G, Perrotti D, Cucco C, Agnano I, Sacchi A, Zupi G and Calabretta B: Inhibition of leukemia cell proliferation by receptor mediated uptake of c-myb antisense oligonucleotides. Proc Natl Acad Sci USA 89: 7031-7035, 1992.
6. McManaway ME, Neckers LM, Loke SL, Al-Nadsser AA, Redner RL, Shiramizu BT, Goldschmidts, WL, Huber BE, Bhatia K and Magrath IT: Tumor specific inhibition of lymphoma growth by an antisense oligonucleotide. Lancet 335: 808-811, 1990.
7. Gewirtz AM and Calabretta B: A c-myb antisense oligodeoxy-nucleoitde inhibits normal human hematopoesis in vitro. Science 242: 1303-1306, 1988.
8. 1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 245: 180-183, 1989.
9. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szcylik C, Venturelli D, Ratajczak MZ, Beran M and Gerwirtz AM: Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb. Antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88: 2351-2355, 1991.
10. Anfossi G, Gewirtz AM and Calabretta B: An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci USA 86: 3379-3383, 1989.
11. Ratajczak MZ, Hijiya N, Catani L, DeRiel K, Luger S, McGlave P and Gewirtz AM: Acute and chronic phase myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligonucleotides. Blood 79: 1956-1961, 1992.
12. Ratajczak MZ, Kant JA, Luger S, Hijiya N, Zhang J, Zon G and Gewirtz AM: In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligonucleotides. Proc Natl Acad Sci USA 89: 1710-1714, 1992.
13. Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G and Gerwirtz AM: In vivo treatment of human leukemia in a scid model with c-myb antisense oligonucleotides. Proc Natl Acad Sci USA 89: 11823-11827, 1992.
14. Draper A and Brown D: Reduction in herpes simplex virus infection using phosphorothioate oligonucleotide complementary to viral mRNA. Antivir Res Suppl 1: 106-114, 1991.
15. Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ, Whalen VL and Bishop M: Effects of BCR-ABL antisense oligonucleotides (AS-ODN) human chronic myeloid leukemic cells: As-ODN as effective purging agents. Leuk Lymphoma (In press).
16. Telford WG, King LE and Fraker PJ: Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Proliferation 24: 447-459, 1991.
17. Majello B, Kenyon LC and Dalla-Favara R: Human c-myb proto-oncogene: nucleotide sequence of cDNA and organization of the genomic locus. Proc Natl Acad Sci USA 83: 9636-9640, 1986.
18. Telford WG, King LE and Fraker PJ: Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degredation by flow cytometry. Cytometry 13: 137-143, 1992.